These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14572143)

  • 41. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.
    Dietrich J; Lacagnina M; Gass D; Richfield E; Mayer-Pröschel M; Noble M; Torres C; Pröschel C
    Nat Med; 2005 Mar; 11(3):277-83. PubMed ID: 15723074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
    Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R
    Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutations.
    Slynko I; Nguyen S; Hamilton EMC; Wisse LE; de Esch IJP; de Graaf C; Bruning JB; Proud CG; Abbink TEM; van der Knaap MS
    Mol Genet Genomic Med; 2021 Mar; 9(3):e1593. PubMed ID: 33432707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. eIF2B-related multisystem disorder in two sisters with atypical presentations.
    Lee JS; Lee S; Choi M; Lim BC; Choi J; Kim KJ; Cheon JE; Kim IO; Chae JH
    Eur J Paediatr Neurol; 2017 Mar; 21(2):404-409. PubMed ID: 28041799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.
    Schiffmann R; Elroy-Stein O
    Mol Genet Metab; 2006 May; 88(1):7-15. PubMed ID: 16378743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vanishing white matter disease with different faces.
    Güngör G; Güngör O; Çakmaklı S; Maraş Genç H; İnce H; Yeşil G; Dilber C; Aydın K
    Childs Nerv Syst; 2020 Feb; 36(2):353-361. PubMed ID: 31385086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease.
    Wu Y; Pan Y; Du L; Wang J; Gu Q; Gao Z; Li J; Leng X; Qin J; Wu X; Jiang Y
    J Hum Genet; 2009 Feb; 54(2):74-7. PubMed ID: 19158808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients.
    Ren Y; Yu X; Chen B; Tang H; Niu S; Wang X; Pan H; Zhang Z
    Neurol Sci; 2022 Aug; 43(8):4961-4977. PubMed ID: 35389136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion of a normal MRI into an MRI showing a cystic leukoencephalopathy is not a known feature of vanishing white matter.
    van der Knaap MS; Schiffmann R; Scheper GC
    Neuropediatrics; 2007 Oct; 38(5):264. PubMed ID: 18330844
    [No Abstract]   [Full Text] [Related]  

  • 50. Vanishing white matter disease in a spanish population.
    Turón-Viñas E; Pineda M; Cusí V; López-Laso E; Del Pozo RL; Gutiérrez-Solana LG; Moreno DC; Sierra-Córcoles C; Olabarrieta-Hoyos N; Madruga-Garrido M; Aguirre-Rodríguez J; González-Álvarez V; O'Callaghan M; Muchart J; Armstrong-Moron J
    J Cent Nerv Syst Dis; 2014; 6():59-68. PubMed ID: 25089094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease.
    Shimada S; Miya K; Oda N; Watanabe Y; Kumada T; Sugawara M; Shimojima K; Yamamoto T
    Am J Med Genet A; 2012 Jul; 158A(7):1771-7. PubMed ID: 22678813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple Sclerosis and EIF2B5: A Paradox or a Missing Link.
    Zahoor I; Haq E; Asimi R
    Adv Exp Med Biol; 2017; 958():57-64. PubMed ID: 28093708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients.
    Benzoni C; Moscatelli M; Farina L; Magri S; Ciano C; Scaioli V; Alverà S; Cammarata G; Bianchi-Marzoli S; Castellani M; Zito FM; Marotta G; Piacentini S; Villacara A; Mantegazza R; Gellera C; Durães J; Gouveia A; Matos A; do Carmo Macário M; Pareyson D; Taroni F; Di Bella D; Salsano E
    J Neurol; 2023 Sep; 270(9):4219-4234. PubMed ID: 37171481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vanishing white matter disease: a review with focus on its genetics.
    Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS
    Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of genotype on the natural history of eIF2B-related leukodystrophies.
    Fogli A; Schiffmann R; Bertini E; Ughetto S; Combes P; Eymard-Pierre E; Kaneski CR; Pineda M; Troncoso M; Uziel G; Surtees R; Pugin D; Chaunu MP; Rodriguez D; Boespflug-Tanguy O
    Neurology; 2004 May; 62(9):1509-17. PubMed ID: 15136673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotype-phenotype correlation in vanishing white matter disease.
    van der Lei HD; van Berkel CG; van Wieringen WN; Brenner C; Feigenbaum A; Mercimek-Mahmutoglu S; Philippart M; Tatli B; Wassmer E; Scheper GC; van der Knaap MS
    Neurology; 2010 Oct; 75(17):1555-9. PubMed ID: 20975056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adult Vanishing White Matter Disease with a Novel EIF2B4 Mutation.
    Su T; Yuan H; Gao W; Li H; Yuan M
    J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS181-SS183. PubMed ID: 36597332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vanishing White Matter With Hepatomegaly and Hypertriglyceridemia Attacks.
    Unal O; Ozgen B; Orhan D; Tokatli A; Hismi BO; Dursun A; Coskun T; Kalkanoglu-Sivri HS
    J Child Neurol; 2013 Nov; 28(11):1509-1512. PubMed ID: 22992991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mutations identified in EIF2B5 gene in Kashmiri patients as susceptibility factor for multiple sclerosis.
    Zahoor I; Hamid Z; Asimi R; Haq E
    Indian J Biochem Biophys; 2014 Apr; 51(2):115-20. PubMed ID: 24980014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.
    Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N
    Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.